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Abstract 
Background 
The human pathogen Mycobacterium tuberculosis has the capacity to escape eradication by 
professional phagocytes. During infection, M. tuberculosis resists the harsh environment of 
phagosomes and actively manipulates macrophages and dendritic cells to ensure prolonged 
intracellular survival. In contrast to other intracellular pathogens, it has remained difficult to 
capture the transcriptome of mycobacteria during infection due to an unfavorable host-to-
pathogen ratio. 
Results 
We infected the human macrophage-like cell line THP-1 with the attenuated M. tuberculosis 
surrogate M. bovis Bacillus Calmette–Guérin (M. bovis BCG). Mycobacterial RNA was up to 
1000-fold underrepresented in total RNA preparations of infected host cells. We employed 
microbial enrichment combined with specific ribosomal RNA depletion to simultaneously 
analyze the transcriptional responses of host and pathogen during infection by dual RNA 
sequencing. Our results confirm that mycobacterial pathways for cholesterol degradation and 
iron acquisition are upregulated during infection. In addition, genes involved in the 
methylcitrate cycle, aspartate metabolism and recycling of mycolic acids were induced. In 
response to M. bovis BCG infection, host cells upregulated de novo cholesterol biosynthesis 
presumably to compensate for the loss of this metabolite by bacterial catabolism. 
Conclusions 
Dual RNA sequencing allows simultaneous capture of the global transcriptome of host and 
pathogen, during infection. However, mycobacteria remained problematic due to their 
relatively low number per host cell resulting in an unfavorable bacterium-to-host RNA ratio. 
Here, we use a strategy that combines enrichment for bacterial transcripts and dual RNA 
sequencing to provide the most comprehensive transcriptome of intracellular mycobacteria to 
date. The knowledge acquired into the pathogen and host pathways regulated during infection 
may contribute to a solid basis for the deployment of novel intervention strategies to tackle 
infection. 
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Background 
Tuberculosis (TB) is an infectious disease caused by the airborne pathogen Mycobacterium 
tuberculosis and accounts for 1.3 million fatalities annually [1]. Unlike non-pathogenic 
microbes that are eliminated inside the maturing phagosome of immune cells such as 
macrophages, M. tuberculosis brings phagosome maturation to a halt and manages to cope 
with various host threats including acidification, reactive radicals and nutrient limitation [2]. 
Studying the transcriptome of intracellular pathogens, in particular M. tuberculosis, during 
infection remained difficult due to a low bacteria-to-host RNA ratio. For different pathogens 
the number of organisms per host cell spans several orders of magnitudes ranging from 1 to 
10 for M. tuberculosis and up to 1000 for Chlamydia [3,4]. 
The first insights into the intracellular life of M. tuberculosis provided by comparative 
microarray analysis, revealed a switch from aerobic to anaerobic respiration, induction of the 
dormancy regulon dosR and iron scavenging as well as upregulation of β-oxidation of fatty 
acids upon infection [5]. Similar technologies and quantitative real-time PCR were applied to 
broaden our understanding of specific aspects of intracellular M. tuberculosis [6-9]. 
Microarray probes have the disadvantage of unspecific cross-hybridization between pathogen 
and host [4], and most often such probes are not optimized for minimal cross-reactivity with 
other species. Cappelli and colleagues [8] estimated that non-specific signals account for up 
to 12.5% of all signals. Additionally, transcription of non-coding regions and missed or miss-
annotated genes often remain disregarded due to a limited array design. Quantitative real-
time PCR has mostly been applied to small subsets of genes, since detection of each 
transcript requires a pair of specific oligonucleotides [6-9]. 
Dual RNA sequencing (dual RNA-seq) is a relatively novel technique to study gene 
expression profiles. This technique allows unbiased and simultaneous sequencing of 
transcriptomes of multiple organisms and therefore is a superb technology to study 
intracellular pathogens during infection of host cells. The sequencing reads can subsequently 
be matched in-silico to the respective organism. Without prior knowledge of sample content, 
its composition can be deduced from dual RNA-seq datasets without targeting specific 
species [10]. Most importantly, dual RNA-seq captures the transcriptome in its entirety 
thereby overcoming the limitations of microarrays discussed above. First application of this 
technology to study M. avium subsp. paratuberculosis during macrophage infection has shed 
new light on mycobacterial iron acquisition [11]. 
The attenuated TB vaccine strain M. bovis Bacillus Calmette–Guérin (M. bovis BCG) has 
been widely used in research as surrogate for pathogenic M. tuberculosis due to a high degree 
of genome identity [12-14]. In this study, we investigated the transcriptional adaptation of M. 
bovis BCG 24 hours after infection of the human macrophage-like cell line THP-1 by dual 
RNA-seq. The underrepresentation of bacterial RNA in preparations of total RNA from 
infected host cells requires high sequencing depth to gain statistical significance and adequate 
pathogen coverage, leading to increased costs. Mangan and colleagues developed a method 
entailing differential lysis with guanidine thiocyanate to enrich for mycobacteria from 
infected macrophages, thus avoiding massive underrepresentation of bacterial RNA as 
compared to total RNA preparations of infected cells [15]. This method has been used for in 
vivo transcriptome studies using microarrays [6,16]. Here we present a strategy that combines 
bacterial enrichment for bacterial transcripts and dual RNA-seq, which we evaluate against 
non-enriched samples. 
Results 
Twenty-four hours post-infection, THP-1 cells were harvested and total RNA was isolated. 
Additionally, two out of three infected THP-1 samples were enriched for M. bovis BCG 
bacilli, using the procedure described in Materials and Methods. The analysis of the 50-bp 
RNA-derived paired-end sequencing data is illustrated in Figure 1. Two out of the three 
datasets derived from the non-enriched infections (IF1/2) were compared to a reference 
sample with uninfected THP-1 cells (THP) and differentially expressed THP-1 genes were 
identified. For differential M. bovis BCG gene and small RNA expression analysis, the 
datasets derived from enriched infections (IF1/2ER) were compared to a reference culture of 
exponentially growing M. bovis BCG (EGB). A spike-in sample (SPI) was used to estimate 
the percentage of infected cells and to correlate the reads of spiked-in M. bovis BCG with the 
M. bovis BCG culture and the non-enriched THP-1 infections with M. bovis BCG. An 
overview of the primary sequencing data is depicted in Table 1. 
Figure 1 Schematic overview of RNA sequencing data analysis. A total of eight datasets 
were processed by aligning the 50-bp paired-end sequencing reads to the human 
transcriptome, the M. bovis BCG genome, and/or the M. bovis BCG gene and small RNA 
sequences. Six of these datasets were used for differential gene and/or small RNA expression 
analysis. (THP: Reference dataset for the THP-1 transcriptome, EGB: Reference dataset for 
the (exponentially growing) M. bovis BCG transcriptome, SPI: Spike-in dataset, IF0/1/2: 
Datasets of M. bovis BCG bacilli infecting THP-1 cells, IF1/2ER: Datasets of M. bovis BCG 
cells infecting THP-1 cells enriched for M. bovis BCG bacilli). 
Table 1 Reads (millions and percentages) mapped on the human transcriptome and the 
M. bovis BCG genome 
  Human transcriptome M. bovis BCG genome  
Dataset Description M of reads % M of reads % Total 
THP Uninfected THP-1 cells 30.9 100 – – 30.9 
EGB M. bovis BCG bacilli – – 168 100 168 
SPI Mixed THP-1 and M. bovis BCG RNA 31.8 91.0 3.16 9.0 35.0 
IF0 Infected THP-1 cells replicate 0 21.5 98.0 0.45 2.0 21.9 
IF1 Infected THP-1 cells replicate 1 38.2 96.0 1.57 4.0 39.7 
IF2 Infected THP-1 cells replicate 2 28.0 96.3 1.07 3.7 29.0 
IF1ER Infected THP-1 cells replicate 1 enriched 
for M. bovis BCG bacilli 
18.0 74.7 6.09 25.3 24.0 
IF2ER Infected THP-1 cells replicate 2 enriched 
for M. bovis BCG bacilli 
26.0 88.6 3.35 11.4 29.4 
Pathogen specific enrichment strategy is effective 
It has been estimated that a minimum of 2–5 million reads from a ribosomal RNA-depleted 
library is required to adequately cover the gene expression profile of a pathogen in a dual 
RNA-seq experiment [17-19]. Datasets IF0, IF1 and IF2, derived from non-enriched 
infections contained 0.4, 1.6 and 1.1 million 50-bp reads that aligned to the M. bovis BCG 
genome, which was too low for significant coverage of the gene expression profile. 
Subsequently, an enrichment strategy for M. bovis BCG was applied to overcome this 
obstacle, thereby increasing the coverage of intracellular M. bovis BCG transcripts. These 
enriched datasets (IF1ER and IF2ER) contained 6.1 and 3.3 million 50-bp reads that aligned 
to the M. bovis BCG genome (Table 1). 
The absolute number of M. bovis BCG reads of all infected sample preparations was 
subsequently classified in four different categories: protein-coding RNA, ribosomal RNA, 
small RNA, and other (Figure 2A). We simulated the relationship between the number of 
identified differentially expressed protein-coding M. bovis BCG genes and sequencing depth 
(Figure 2B). For very low numbers of sequencing reads, the number of identified genes 
increases in a linear way with the library size. With increasing library size the number of 
correct identifications tends to stabilize (Figure 2B). The relative abundance of the four 
different categories was fairly similar in both, enriched and non-enriched samples, 
demonstrating that impact of enrichment per se on M. bovis BCG derived sequencing reads is 
negligible (Figure 2C). The normalized counts of the protein coding M. bovis BCG 
transcripts in the enriched datasets (IF1ER and IF2ER) and the non-enriched datasets (IF1 
and IF2) revealed a linear relationship, with Pearson’s correlation coefficients of 0.91 and 
0.92, respectively (Additional file 1). We conclude that pathogen enrichment does not 
introduce any bias to protein-coding gene expression of M. bovis BCG. However, the 
correlation for normalized counts per gene of THP-1 reads between the same datasets is much 
lower, 0.57 and 0.70, respectively (Additional file 1). Therefore, the non-enriched datasets 
(IF1 and IF2) were used for differential gene expression analysis of THP-1 genes. This 
enrichment procedure thus enabled us to study the intracellular gene expression of M. bovis 
BCG during infection. 
Figure 2 Classification of 50-bp sequencing reads and effect of increasing sequencing 
depth. (A) The total number of 50-bp sequencing reads, matching the paired-end analysis 
criterion that both reads could be aligned to the M. bovis BCG genome, were assigned to four 
different categories (protein-coding RNA, ribosomal RNA, small RNA, and other). The total 
of the reads for each sample represents the number of reads aligning to the M. bovis BCG 
genome. (B) Simulation of the relation between the number of differentially expressed M. 
bovis BCG genes and sequencing depth. Random subsets of reads were selected from EGB, 
IF1ER and IF2ER and the mean number (n = 5) of reliably identified differentially expressed 
genes (FDR < 0.05) and the standard deviation (error bars) are given for various sequencing 
depths. Note that the ratio of a random set to the total set approaches 1 as the size of the 
random set increases. Therefore, the random samples become more similar to each other and 
the standard deviation decreases. For reasons of completeness, we have included a standard 
deviation for every point. (C) Classification of the relative number of 50-bp paired-end 
sequencing reads aligning to the M. bovis BCG genome. The legend is the same as in (A). 
M. bovis BCG response to infection 
Twenty-four hours post-infection a clear response of the phagocytosed M. bovis BCG bacilli 
can be observed on the transcriptome level. A total of 367 M. bovis BCG genes were 
differentially expressed (FDR < 0.05), of which 216 were induced and 151 were repressed. A 
list of all differentially expressed genes of both M. bovis BCG and THP-1 cells is provided in 
Additional file 2. 
M. bovis BCG cholesterol catabolism genes are induced during infection 
Cholesterol is a complex lipid that consists of three cyclohexane rings (A, B and C), a 
cyclopentane ring (D), and an 8-carbon side chain. An incomplete degradation pathway of 
cholesterol was recently proposed for M. tuberculosis [20]. This pathway was extended with 
the side chain degradation of rings C and D (Additional file 3) and several genes involved in 
the pathway were added based on additional literature [21-28]. This extended cholesterol 
degradation pathway has been previously described in a genome-scale metabolic model of M. 
tuberculosis [29]. 
We observed a strong increase in expression of almost all genes assigned to cholesterol 
degradation (Figure 3A and Additional file 3). Initially, cholesterol is taken up by the 
transport system encoded by the mce4 gene cluster [30]. The 3β-hydroxyl group is oxidized 
and isomerized to cholest-4-en-3-one either by the membrane-bound oxidase ChoD or by the 
dehydrogenase HsdD [21,31]. No apparent induction of the mce4 operon, the hydroxysteroid 
dehydrogenase (HsdD) and cholesterol oxidase (ChoD) coding genes was observed in our 
datasets. However, the number of transcript reads assigned to the mce4 operon and to choD 
and hsdD indicate that they were expressed in both the infectious and the non-infectious state 
(Data set S1). 
Figure 3 Metabolic processes during infection. Genes in green are induced upon infection 
(FDR < 0.05), genes in red are repressed (FDR < 0.05) and genes in black show no 
differential expression. (A) Cholesterol degradation is divided in three parts: The degradation 
of the side chain (yellow part), degradation of rings A and B (red part) and the degradation of 
the side chain of rings C and D (blue part). Dashed arrows represent multiple reactions. The 
degradation of the rings C and D side chain is based on homologous genes from Rhodococcus 
equi. AD: 4-androstenedione, ADD: 1,4-androstenedione, 9OHADD: 9-hydroxy-1,4, 
androstene-3-17-dione, 3-HSA: 3-hydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione 
3,4-DHSA: 3,4-dihydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione 4,9 DSHA: 4,5-
9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oic acid, HIP: 9,17-dioxo-
1,2,3,4,10,19-hexanorandrostan-5-oic acid, 5OH-HIP: 5-hydroxy-methylhexahydro-1-
indanone propionate. (B) Aspartate could be imported via AnsP2 and used for the synthesis 
of vitamin B5, glutamate and methionine. thrB, dapA and nadABC are downregulated, 
indicating that aspartate is to a lesser extent used to synthesize threonine, lysine and NAD(P). 
Although the degradation of rings A and B is well established, the side chain degradation of 
rings C and D (Figure 3A and Additional file 3) is less understood in mycobacteria and 
therefore was reconstructed based on orthology with Rhodococcus equi genes [22,26]. 
KstR and KstR2 (BCG3639, BCG3621c; Rv3574, Rv3557c) have been previously identified 
as regulators of cholesterol utilization in mycobacteria [32]. The KstR2 regulon comprises 
kstR2 itself and all genes linked to the degradation of the side chain of rings C and D, 
whereas genes regulated by KstR participate in the degradation of rings A and B and the 
initial degradation of the cholesterol side-chain (Figure 3A and Additional file 3). In our 
datasets the expression of kstR2 was strongly induced upon infection, whereas kstR remained 
unchanged (Data set S1). To verify these findings and the expression of other genes we 
selected a subset of 14 genes, of which 3 encode small RNAs, and designed primers 
(Additional file 4) to use for qRT-PCR. Among the selected genes, 5 genes are involved in 
cholesterol catabolism and 2 genes encode enzymes of the methylcitrate cycle (Additional 
file 5). The qRT-PCR results confirmed the integrity of our RNA-seq data. 
We analyzed the behavior of the genes in the cholesterol degradation pathway in a 
compendium of expression data collected for M. tuberculosis. Although no condition 
associated with cholesterol utilization has been included in the compendium, many conditions 
in our compendium lead to differential expression of genes regulated by KstR and KstR2 
(Figure 4). Yet, a reduced set of KstR2-regulated genes (fadD3, fadE31 and ipdA) exists, 
which seems to be specifically induced upon infection and most likely specifically reacts to 
only this kind of perturbation. The specific induction renders fadD3, fadE31 and ipdA of 
potential interest for therapeutic intervention. Bioinformatics analysis using the consensus 
IdeR binding motif [33] and the KstR2 binding motif [32] revealed that these regions overlap 
(Figure 5). 
Figure 4 Variance in expression levels (compendium) compared to the fold changes 
upon infection. Genes in blue are KstR2-regulated whereas orange genes denote KstR-
regulated genes. Genes in black show no significant change (FDR > 0.05). Green/violet 
ellipses denote areas of high/low variability in the expression compendium. *In M. 
tuberculosis H37Rv, cyp142 has the same function as cyp125. In M. bovis BCG, cyp142 
encodes an inactive product. 
Figure 5 Regulation of the cholesterol degradation pathway by IdeR, KstR and KstR2. 
Sequences similar to the IdeR binding boxes appear in the upstream regions of genes in the 
cholesterol degradation pathway in close proximity to (and sometimes overlapping with) the 
KstR and KstR2 binding regions. (A, B and C) Under either normal iron availability or lack 
of cholesterol either IdeR or KstR/KstR2 represses the expression of genes in this pathway. 
(D) Only under low iron availability (relieving IdeR repression) and in presence of 
cholesterol (relieving KstR and KstR2 repression), can the genes in the cholesterol 
degradation pathway be expressed. 
Griffin and co-workers [34] found that although propionyl-CoA can be derived from other 
host metabolites, the requirement for the methylcitrate cycle is largely attributable to the 
degradation of host cholesterol. The induction of the methylcitrate cycle and the slight 
repression of icd1 (BCG3409c; Rv3339c), encoding an isocitrate dehydrogenase, suggests 
that the oxidative part of the citric acid cycle is bypassed in favor of this pathway (Additional 
file 6). This emphasizes that cholesterol is the main carbon source for intra-phagosomal M. 
bovis BCG. 
Expression profile suggests M. bovis BCG recycles mycolic acids 
Mycobacterial fatty acids are precursors for mycolic acids and are synthesized by at least two 
fatty acid synthases: FAS-I and FAS-II [35]. FAS-I consists of a single multifunctional 
enzyme, encoded by fas (BCG2545c; Rv2524c), and elongates fatty acids at the beginning of 
the mycolic acid synthesis pathway, while FAS-II consists of multiple enzymes and elongates 
fatty acids created by FAS-I. The mycobacterial genes umaA1, cmaA2, hadA, and mmaA3 
(BCG0509, BCG0546c, BCG0684, BCG0692c; Rv0469, Rv0503c, Rv0635, Rv0643) encode 
enzymes that further process FAS-II products (Figure 6). Previous reports suggested that 
FadE23 and FadE24 (BCG3163, BCG3162; Rv3140, Rv3139) might be involved in recycling 
of mycolic acids [24]. Taken together, the expression patterns observed in our study (Figure 
6) indicate that new acids are rather generated by remodeling existing mycolic acids and host 
fatty acids than synthesized de-novo. 
Figure 6 M. bovis BCG gene expression pattern of mycolic acid synthesis. Genes involved 
in fatty acid synthase II (FAS-II) and downstream of FAS-II are induced (green), while fatty 
acid synthase I (FAS-I) is repressed (red). 
Expression pattern of intracellular M. bovis BCG suggests utilization of host 
aspartate 
Gouzy and colleagues showed that nitrogen incorporation from exogenous aspartate is 
required for host colonization by M. tuberculosis [36]. We observed changes in the gene 
expression pattern upon infection, regarding aspartate metabolism (Figure 3B). Intriguingly, 
the gene encoding the unique aspartate importer AnsP1 (BCG2144; Rv2127) showed no 
significant change in expression, while its homolog ansP2 (BCG0385c; Rv0346c) showed a 
two-fold induction (Data set S1). Gouzy and colleagues found that an M. tuberculosis ansP2-
knock-out (KO) mutant was able to grow on aspartate as sole nitrogen source [36]. Moreover, 
an ansP1 mutant showed no growth defect in either resting or activated macrophages. The 
lack of induction of the sole asparaginase gene ansA (BCG1590c; Rv1538c), that can 
catalyze the conversion of asparagine to aspartate, suggests that, in addition to its reported 
asparagine transport capacity [37], mycobacterial AnsP2 imports aspartate from the 
phagosome during infection. Some of the genes that encode aspartate-utilizing enzymes are 
induced, such as panD and aspB (BCG3665c, BCG3629; Rv3601c, Rv3565). In particular, 
AspB was predicted to transfer nitrogen from aspartate to glutamate, which serves as a 
central nitrogen carrier for alternative metabolic pathways [38], suggesting that M. bovis 
BCG utilizes host aspartate as nitrogen source during infection. 
The repression of de novo NAD(P) synthesis genes nadA, nadB and nadC (BCG1632, 
BCG1633, BCG1634; Rv1594, Rv1595, Rv1596) and the absence of significant changes in 
expression of pncA, pncB, nadD and nadE (BCG2062c, BCG1392c, BCG2437c, BCG2457c; 
Rv2043c, Rv1330c, Rv2421c, Rv2438c) involved in NAD(P) synthesis and salvage [39] 
(Data set S1), indicates that bacterial NAD(P) may become limited during infection. The 
transcripts of enzymes catalyzing branching reactions towards threonine, methionine and 
lysine showed an unexpected pattern (Figure 3B): both dapA (BCG2769c; Rv2753c) and thrB 
(BCG1356; Rv1296), involved in initiation of threonine and lysine biosynthesis respectively 
were repressed, while metX (BCG3411; Rv3341), encoding an enzyme that initiates 
methionine biosynthesis, was induced. We conclude that host aspartate utilized by M. bovis 
BCG might largely be converted into methionine rather than threonine and lysine. 
The induction of sodA (BCG3909; Rv3846) (Data set S1), encoding superoxide dismutase 
that destroys harmful radicals, confirms that M. bovis BCG counteracts reactive oxygen 
intermediates (ROI) produced by the host cell [2,40]. Interestingly, aspartate has the capacity 
to quench ROI by intramolecular oxidation of the sulphur atom [41]. Although experimental 
prove has yet to be provided, it is attractive to speculate that mycobacteria produce 
methionine during infection to support counteraction to ROI. 
M. bovis BCG iron scavenging; siderophore synthesis, secretion and import 
Mycobactins comprise an essential class of mycobacterial siderophore molecules to access 
iron of the host. These molecules are synthesized by an array of mycobactin enzymes, 
consisting of several proteins organized in a megasynthase [42]. The mycobactin 
megasynthase genes mbtB–F were induced upon infection and so were the majority of 
additional genes involved in mycobactin biosynthesis: mbtG/I/J/K/N (BCG2392c, 
BCG2400c, BCG2399, BCG1409c, BCG1408; Rv2378c, Rv2385, Rv2386c, Rv1347c, 
Rv1346) (Data set S1). 
The type VII secretion system ESX-3 is essential for mycobactin-mediated iron acquisition 
and in vivo survival [43]. The ESX-3 secretion system is regulated by ZuR (BCG2373; 
Rv2359) [44] and consists of 11 genes [45] of which 7 were induced upon infection (Data set 
S1). The repression of zuR, resulted in the induction of ESX-3. A siderophore transport 
system of M. tuberculosis consisting of MmpL4 and MmpS4 (BCG0489c, BCG0490c; 
Rv0450c, Rv0451c) is required for infection of mice [46]. Both mmpL4 and mmpS4 and two 
other genes encoding an inner membrane transporter for mycobactin irtA/B [47] 
(BCG1410/1411; Rv1348/1349) were induced (Data set S1). Of the bacterioferritins BfrA/B 
(iron storage proteins induced by IdeR), only bfrB (BCG3904; Rv3841) showed a significant 
decrease. A possible explanation could be the reduced availability of iron in the host, and 
thus less iron storage capacity is required. 
M. bovis BCG small RNAs 
Small RNAs have only recently been discovered in Mycobacteria [48,49]. Although their 
function is mostly unclear, they can be present in large quantities [50]. In our study, 
differential expression was observed for 19 small RNAs (FDR < 0.05). High transcript levels 
of the small RNAs MTS0997, MTS1338 and MTS2823 were reported in chronically M. 
tuberculosis-infected mouse lungs [50]. We observed a significant (FDR < 0.05) induction of 
MTS2823 as well, although the fold change is small (logFC = 1.49) compared to other 
reports. The expression of MTS1338 was repressed in our study, and showed a small fold 
change (logFC = −2.03). DosR (BCG3156c; Rv3133c) induces the latter in M. tuberculosis 
upon hypoxia and infection [51]. The low expression (below 100 CPM) and lack of induction 
of dosR in our datasets, may explain why MTS1338 remained unchanged. We verified the 
RNA-seq data by qRT-PCR (Additional file 5). Whether the contrary expression of 
MTS1338 in M. bovis BCG and in M. tuberculosis during infection is critical for virulence 
remains to be defined. 
Host immune response to M. bovis BCG is AIM2 dependent 
A pathway enrichment analysis using InnateDB [52] revealed that the THP-1 cells show 
distinct signs of infection (Table 2) since we identified numerous enriched pathways involved 
in immune response such as IFN-α/β signaling, IFN-γ signaling and RIG-I/MDA5-mediated 
induction of IFN-α/β pathways. Interferons (IFNs) are synthesized by the host upon infection 
and trigger the activation of its immune system. IFNs can be divided in three classes: type I 
IFNs (IFN-α, IFN-β, IFN-ε and IFN-ω), type II IFNs (IFN-γ) and type III IFNs [53]. 
  
Table 2 Induced THP-1 pathways upon M. bovis BCG infection 
Pathway name Number of genes annotated 
in pathway 
Number of induced 
genes 
P-Value 
IFN-α/β signaling 36 23 <1.0 × 10−5 
IFN-γ signaling 28 16 <1.0 × 10−5 
RIG-I/MDA5-mediated induction of 
IFN-α/β pathways 
12 8 <1.0 × 10−5 
Cytosolic DNA-sensing pathway 23 8 0.00018 
Cholesterol biosynthesis 14 6 0.0033 
Hepatitis C 71 14 0.00073 
Staphylococcus aureus infection 11 5 0.00078 
Steroid biosynthesis 11 5 0.00078 
Iron uptake and transport 7 4 0.00096 
Toxoplasmosis 60 12 0.00152 
The ten most significantly induced pathways are shown. 
Shah and colleagues [54] showed that virulent mycobacteria, such as M. tuberculosis inhibit 
IFN-β production and signaling, resulting in the inhibition of the activation of AIM2 
(interferon-inducible protein). AIM2 is part of the inflammasome that recognizes cytosolic 
bacterial and viral DNA, thereby contributing to the host's defense. In contrast to virulent 
mycobacteria, nonvirulent mycobacteria such as M. smegmatis, induce AIM2 [54]. M. bovis 
BCG seems to respond similarly to other nonvirulent mycobacteria, as the transcription of the 
gene encoding AIM2 is highly induced (Data set S1) as well as the IFN-α/β signaling 
pathway and the cytosolic DNA-sensing pathway (Table 2). 
Host genes involved in glycolysis and ketogenesis are induced upon 
mycobacterial infection 
Phagocytosis of pathogenic mycobacteria triggers the accumulation of lipid bodies in the host 
cell described as foamy phenotype [55]. Secretion of mycobacterial ESAT-6 is required to 
mediate this process by stimulating the uptake of glucose into the host cell, which might lead 
to increased glycolytic activity and elevated levels of acetyl-CoA, which in turn leads to the 
generation of D-3-hydroxybutyrate via ketogenesis [55]. Although M. bovis BCG lost the 
ESX-1 locus, a major virulence determinant of pathogenic mycobacteria that encodes the 
effector proteins ESAT-6 and CFP-10 [13,56], we observe increased expression of several 
glycolytic enzymes including HK3, GPI, PFKP, FBPI, GAPDH, and PGAM1 (Additional file 
2). Moreover, we found genes of the ketogenesis pathway induced: ACAT2, HMGCS1, 
BDH2 and HMGCR. The latter gene encodes HMG-CoA reductase, which catalyzes the 
conversion of hydroxy-β-methylglutaryl CoA and leads to the synthesis of cholesterol and 
other sterols. BDH2 encodes 3-hydroxybutyrate dehydrogenase, which catalyzes the 
reversible conversion of acetoacetate to D-3-hydroxybutyrate. Subsequent steps that lead to 
mycobacteria-induced formation of lipid bodies in the host cell involve the activation of the 
anti-lipolytic G protein-coupled receptor GPR109A, which triggers adenylyl cyclase. The 
resulting decrease in host cyclic AMP levels leads to a decrease in phosphorylation of stored 
host lipids by protein kinase A (PKA), rendering them less vulnerable to lipolysis by 
hormone sensitive lipase (HSL), thus promoting the formation of lipid bodies [55]. Consistent 
with the attenuated M. bovis BCG strain, we do not observe a change in the expression of 
GPR109A, adenylyl cyclase, PKA and HSL, indicating that this part of the pathway leading 
to the formation of lipid bodies is not active in the host or that this response is regulated post-
transcriptionally and therefore remains invisible using a transcriptome approach. 
Taken together, despite the absence of the ESX-1 locus in M. bovis BCG, the host response 
regarding the initial steps of lipid body formation is similar to that of M. tuberculosis. Several 
pathogen factors including mycolic acids that were demonstrated to induce the foamy 
phenotype in macrophages [57], may therefore be required to reprogram the host for lipid 
build-up. 
Cholesterol is synthesized and iron losses are compensated by the host upon 
infection 
Four out of seven genes in the THP-1 iron uptake and transport pathway were induced. The 
enzyme encoded by the induced gene HMOX1 encodes heme oxygenase 1, assigned to iron 
uptake and transport, catalyzes the rate-limiting step of heme degradation and is required to 
confer host resistance to mycobacterial infection in mice [58]. Among the other induced 
genes were FTH1 and FTL, encoding the heavy and light polypeptide of ferritin. This 
suggests that the THP-1 cells compensate for the loss of iron caused by M. bovis BCG, by 
taking up extra iron and degrading heme. 
The THP-1 cholesterol biosynthesis pathway was induced, as six genes of this pathway, 
including HMGCR encoding the rate-limiting enzyme for cholesterol biosynthesis, were 
upregulated. We conclude that infected macrophages synthesize cholesterol to compensate 
for loss of this molecule caused by mycobacterial catabolism. 
Discussion 
This study describes a deep sequencing approach towards the elucidation of mycobacterial 
and host cell gene expression profiles during intracellular infection. Initially we employed 
standard deep sequencing settings for eukaryotes to resolve the transcriptional profile of 
intracellular mycobacteria. Although this set-up allowed, to some extent, analyzing gene 
expression in M. bovis BCG, mycobacterial transcript coverage was insufficient. Increasing 
the sequencing depth was hindered by high sequencing costs, thereby preventing the method 
to become a broad application. Thus, we decided to enrich for mycobacteria during sample 
preparation of infected THP-1 cells. Indeed, the strategy applied greatly increased the 
coverage of the intracellular M. bovis BCG transcriptome. Although mycobacterial gene 
expression can be analyzed in non-enriched samples (215 genes, FDR < 0.05), 
implementation of enrichment greatly expanded the number of reliably identified 
differentially expressed genes by 71% (367 genes, FDR < 0.05). 
Moreover, the sequencing depth simulation (Figure 2B) revealed that enrichment allowed 
identification of differentially expressed genes that would have been missed otherwise. 
Repasy and colleagues showed that for an in vivo infection setting with mice and M. 
tuberculosis the MOI ranges from 1 to 5 [3]. Therefore, when studying an in vivo infection, 
the enrichment might not be sufficient to obtain a similar sequencing depth as obtained in our 
in vitro study, for which an MOI of 10 was used. To determine whether enrichment 
introduced any bias into the datasets, we analyzed non-enriched and enriched samples of two 
independent biological infection replicates. Although the non-enriched and enriched samples 
comprised different numbers of intracellular M. bovis BCG reads, the transcriptomes of 
respective samples of both infection experiments correlated well as indicated by high 
linearity and correlation coefficients (Additional file 1). Additionally, the correlation of 
intracellular M. bovis BCG expression between the biological replicates of both enriched 
datasets was comparable with the non-enriched datasets (0.93 and 0.94, respectively), 
verifying that the enrichment procedure was repeatable and robust, and did not introduce any 
bias to the intracellular mycobacterial transcriptome. For host expression we identified a 
lower correlation between the non-enriched and enriched samples (0.57 for IF1 and IF1ER, 
and 0.70 for IF2 and IF2ER) (Additional file 1). Hence, the datasets of non-enriched samples 
were favored for analysis of the host transcripts in order to preserve accuracy of the 
transcriptional landscape during infection. 
Our method is dependent on differential susceptibility to lysis of host and microbial cells and 
not on a molecular sequence capture or depletion method as previously described [11]. This 
has the added advantage that small RNAs can be detected and analyzed for differential 
expression. Additionally, our method is independent of mRNA polyadenylation, as e.g. 
MICROBEnrich simultaneously captures and removes polyadenylated mRNAs along with 
rRNAs. We consider this a critical point because previous findings support the existence of 
polyadenylated tracts in mRNA of mycobacteria [59] and other bacteria [60,61]. 
It has been shown previously that mycolic acid liposomes are phagocytized by murine 
macrophages, changing the morphology of the macrophages to foam-like cells accumulating 
cholesterol [57]. Although the cholesterol degradation pathway is induced at 24 hours post-
infection (Figure 3A and Additional file 3), the mce4 gene cluster and hsdD and choD were 
not induced. Nonetheless, these genes were expressed in both conditions and respective 
proteins could be already present before infection, ready for a situation when cholesterol 
becomes available. For hsdD and choD, it is tempting to speculate that alternative genes with 
a similar function exist, since these genes have been found dispensable for cholesterol 
degradation in mycobacteria [21]. 
Gene regulation of mycobacterial cholesterol catabolism involves a complex interplay 
between KstR, KstR2, and IdeR. KstR and KstR2 are the prime regulators of the genes 
depicted in Figure 3A. A clear distinction between their targets becomes apparent with KstR 
regulating the degradation of rings A and B and KstR2 regulating the degradation of rings C 
and D. In addition, genes in these regulons (fadA5, fadD3, fadE30, echA20) contain IdeR-
binding sites in their upstream regions [33] and in some cases a profound overlap between 
these binding sites was observed. This implies that these genes can only be expressed upon 
removal of both types of repressors: IdeR under normal iron availability and KstR and KstR2 
during cholesterol shortage (Figure 5). The upregulation of IdeR-dependent iron uptake 
systems can be caused not only by low iron availability inside the macrophage but also as a 
response to the NO-induced damage caused to iron-containing proteins [5]. HsaC, KshA, and 
the cytochromes Cyp125 and Cyp142 are iron-containing enzymes (and hence are susceptible 
to NO-induced damage) and lack of functionality of these enzymes leads to the accumulation 
of stable toxic catabolic intermediates, such as catechol derivatives and cholest-4-en-3-one 
[62-65]. The IdeR control of this pathway ensures that it is only expressed when the 
corresponding repair/replacement systems for iron-containing proteins are in place, therefore 
minimizing the risk of toxic intermediate accumulation. 
It has been shown that aspartate functions as a major nitrogen reservoir in the host [36]. In 
line with this finding, we observed induction of aspartate utilizing enzymes (Figure 3B). 
Interestingly, we did not detect induction of the gene encoding the aspartate transporter 
ansP1, but induction of its homolog, ansP2. Earlier reports demonstrated that an ansP1-KO 
mutant fails to import aspartate in vitro, but shows wild-type behavior in either resting or 
activated macrophages, even though aspartate is a major nitrogen source in the host. 
Moreover, the absence of ansA induction suggests AnsP2 functions as an aspartate importer 
during infection in addition to its role as asparagine importer [37]. 
Rodríguez and colleagues cultivated M. tuberculosis H37Rv on even long-chain fatty acids 
and analyzed the transcriptome by RNA sequencing, observing a dormancy-related 
phenotype [66]. Although there are similarities between their in vitro model and our results, 
the induction of cholesterol catabolism, the methylcitrate cycle and aspartate metabolism are 
not captured using such a method, highlighting the differences between using an in vitro 
model based on even long chain fatty acids as opposed to studying intracellular infection 
directly. 
Conclusions 
Dual RNA-seq allowed elucidation of the complex interplay between M. bovis BCG and 
THP-1 macrophages. The comparison of non-enriched and enriched ribosomal RNA-depleted 
sequencing libraries of two biological replicates from identical infection cultures, showed 
high correlation of sequencing reads without technical bias. Taken together, microbe-
enriched dual RNA-seq is a powerful technology that enables the assessment of the global 
transcriptome of "low-number" intracellular microbes and their host as demonstrated by the 
simultaneous induction of M. bovis BCG cholesterol degradation genes and host cholesterol 
synthesis genes. 
Methods 
Bacterial strains and growth conditions 
M. bovis BCG SSI 1331 (American Type Culture Collection, #35733) was grown in 
Middlebook 7H9 medium (Becton Dickinson) supplemented with 0.05% Tween 80, 0.2% 
glycerol, 10% albumin-dextrose-catalase supplement (Becton Dickinson) (7H9-ADC) or on 
Middlebrook 7H11 agar (Becton Dickinson) containing 0.2% glycerol and 10% oleic acid-
albumin-dextrose-catalase enrichment (Becton Dickinson). Mycobacterial cultures were 
grown to the mid-log phase in 1 L roller bottles (450 cm2) at 37°C and 2 rpm. For CFU 
enumeration, serial dilutions were performed in phosphate-buffered saline containing 0.05% 
Tween 80 and plated on Middlebrook 7H11 agar. Plates were incubated at 37°C for 3–4 
weeks prior to counting. 
Infection of the human macrophage-like cell line THP-1 
The THP-1 cell line (American Type Culture Collection #TIB-202) was maintained in 
Roswell Park Memorial Institute medium 1640 supplemented with 10% fetal calf serum, 2 
mM glutamine, 1 mM sodium pyruvate and 0.05 mM 2-mercapto-ethanol in a humidified 5% 
carbon dioxide atmosphere at 37°C. Estimated 4 × 106 cells/well in a 6-well plate were 
differentiated for 24 h using culture medium containing 40 ng/ml phorbol 12-myristate 13-
acetate. Cells were then washed with fresh culture medium and incubated for 48 h. M. bovis 
BCG was pelleted (3,200 rpm, RT, 10 min), washed twice with phosphate buffered saline and 
resuspended in THP-1 culture medium. THP-1 cells were infected with M. bovis BCG at a 
multiplicity of infection of 10. The M. bovis BCG culture medium suspension was added to 
the differentiated cells, centrifuged for 3 min at 800 rpm and subsequently incubated for 4 h. 
The infection mix was removed, cells were washed twice with pre-warmed PBS and 
incubated with fresh culture medium for 20 h prior to RNA extraction. 
RNA isolation and mycobacterial RNA enrichment of infected cells 
Total RNA from mycobacterial cultures was prepared as previously described [67]. 
Extraction of total RNA from THP-1 cells was prepared with TRIzol reagent using glycogen 
as a carrier according to the suppliers’ recommendation (Life Technologies). Total RNA 
from M. bovis BCG infected THP-1 cells was isolated by abrasive particles in a reciprocal 
shaker with TRIzol [67]. Enrichment of mycobacteria from infected THP-1 cells was carried 
out by differential lysis of host and mycobacterial cells by guanidine thiocyanate (GITC). 
Infected cells were washed with PBS at RT. Cold 4 M GITC was added to the monolayer and 
the cells were transferred to a 1.5-ml screw cap tube. After centrifugation the pellet was 
resuspended in residual GITC and mixed with 1 ml TRIzol containing 20 µg/ml linear 
acrylamide, followed by incubation for 5 min at RT. Bacteria were disrupted by bead beating 
(FastPrep Instrument; two cycles of 30s at maximum speed with cooling on ice between 
cycles). The sample was centrifuged for 1 min at 4°C/13,000 rpm and the supernatant was 
transferred to a 2-ml screw cap tube containing 200 µl chloroform, mixed and incubated at 
RT for 5 min. After centrifugation at 4°C/13,000 rpm for 10 min, RNA was extracted from 
the aqueous phase using the Qiagen RNeasy mini kit including an on-column DNase 
digestion (Qiagen). Quality and quantity of total RNA were assessed using an Agilent 2100 
Bioanalyzer (Agilent Technologies) and a NanoDrop 1000 spectrophotometer (Kisker). 
Calculation of spike-in concentration 
Total RNA of THP-1 cells and M. bovis BCG cultures was determined on the basis of cell 
counts and RNA isolation yield. As the intracellular copy number for a pathogen varies from 
species to species we assumed the most minimal infection rate of one mycobacterium per 
host cell. Therefore a cellular multiplicity of infection of 1:1 was used for mixing host and 
pathogen RNA, resulting in a ratio of 1000:1 total RNA, derived from the proportion of RNA 
abundance per cell between host and pathogen. 
RNA sequencing 
The RNA-seq libraries were prepared according to the TruSeq RNA Sample Preparation v2 
Guide (Illumina) without fragmentation and without size selection. Using an Agilent 
Bioanalyzer high sensitivity DNA kit, we confirmed that the average final library size was 
already approximately 350 bp without fragmentation; therefore the library insert 
fragmentation time at 94°C was set to 0 minutes, as no additional fragmentation step was 
required. Up to 98% of bacterial RNA consists of ribosomal RNA, which can prevent 
adequate coverage of a bacterial transcriptome, using RNA sequencing [68,69]. Therefore, 
the Gram-Positive Bacteria Ribo-Zero (Epicentre) rRNA Magnetic Removal Kit was used to 
remove bacterial rRNA from mycobacterial total RNA. For THP-1 total RNA the Ribo-Zero 
Magnetic Kit Human/Mouse/Rat was used, while depletion of rRNA from infections without 
enrichment as well as the spike-in experiment was done by a two-step procedure with both 
kits. The mycobacterial enriched total RNA preparations of infected cells were depleted with 
the Ribo-Zero Magnetic Gold Kit Epidemiology. All cDNA libraries were checked for 
quality using the DNA-1000 kit (Agilent) on a 2100 Bioanalyzer and quantified with the 
Qubit 2.0 Fluorometer (Life Technologies). Libraries of each consecutive experiment were 
pooled as 4-plex and on-board loaded with a Hi-Seq 1500 instrument. The sequencing 
reaction was carried out as Rapid Run using a TruSeq Rapid PE Cluster Kit and a TruSeq 
Rapid SBS Kit and 2 × 51 cycles including 7 cycles indexing in order to obtain 50-bp paired-
end reads. 
Data analysis pipeline 
A total of eight datasets were created: Uninfected THP-1 cells (dataset: THP), exponentially 
growing M. bovis BCG (dataset: EGB), a spike-in sample consisting of THP-1 RNA and M. 
bovis BCG RNA in a 1000:1 ratio (dataset: SPI), M. bovis BCG-infected THP-1 cells with a 
multiplicity of infection of 10 M. bovis BCG bacilli per THP-1 host cell (dataset IF0), two 
additional independent biological replicates of M. bovis BCG-infected THP-1 cells (datasets: 
IF1 and IF2), and two datasets prepared with the enrichment method using the two biological 
replicates of M. bovis BCG-infected THP-1 cells (datasets: IF1ER and IF2ER). 
All 50-bp paired-end reads from datasets IF1/2ER, IF0/1/2, EGB were aligned, using 
megablast, against the complete genome sequence of M. bovis BCG Pasteur, obtained from 
the NCBI bacterial genome database (ftp.ncbi.hih.gov/genomes/Bacteria) and to the human 
transcriptome obtained from the Ensemble database (www.ensembl.org). If both 50-bp reads 
of a given pair could not be aligned to the human transcriptome, or the M. bovis BCG 
genome, they were discarded from further analysis. The 50-bp paired-end reads aligning to 
the M. bovis BCG genome were subsequently aligned to protein-coding genes, ribosomal 
genes, and small RNA (sRNA) genes. The protein-coding gene sequences and the ribosomal 
gene sequences were obtained from the NCBI database. The sRNA-coding gene sequences 
were obtained from the Bacterial Small Regulatory RNA Database [70] and supplemented 
with sRNA sequences from M. tuberculosis [51]. 
Gene counting procedure 
A single count was assigned to a transcript if a complete pair of reads aligned to the M. bovis 
BCG genome. If only one read of a pair of reads aligned to a given gene, also a single count 
was assigned to this transcript, assuming that the other read could align to an intergenic 
region, or another gene, due to the existence of operons. If a pair of reads would align to two 
different genes, a count was assigned to both genes, resulting in a total of two counts per pair 
of reads. For THP-1 cells, all reads assigned to different splice variants of the same gene were 
counted (one count for each aligned read) and summed. 
Differential gene expression analysis 
The R package edgeR [71] was used for differential gene expression analysis of M. bovis 
BCG and THP-1 genes. Gene and protein functions have been extensively studied in M. 
tuberculosis and therefore the M. tuberculosis (strain H37Rv) orthologs of each M. bovis 
BCG gene were included. Low expression tags receiving less than 100 counts per million in 
two or more of the three datasets: EGB, IF1/2ER (or EGB, IF1/2), were excluded from 
differential expression analysis as described in the edgeR manual. Tags receiving more than 
100 counts per million in the EGB dataset and less than 100 counts per million in either one 
or both replicates of IF1/2ER or IF1/2 were still used to account for large decreases in 
expression upon infection. 
EdgeR is a Bioconductor package designed to identify significant changes between two or 
more groups, given that at least one of the groups has replicated measurements [71], which is 
the case for our experimental setup (Figure 1). The edgeR algorithm models the read counts 
associated to a gene using a negative binomial probability distribution. The variance of this 
distribution takes into account both the stochasticity of the sequencing process and the 
variability associated to biological variation. The common Biological Coefficient of Variance 
(BCV) measures the average dispersion in gene expression values associated to biological 
variability. We used EdgeR to compute the BCV of the corresponding samples prior to 
computing differential expression. For the BCG genes, we obtain a BCV of 0.16 from the 
IF1/2ER samples whereas for the THP-1 genes we obtained a BCV of 0.20 from the IF1/2 
samples. We assumed that the BCV in datasets EGB and THP to be smaller than those in 
datasets IF1/2ER and IF1/2, due to the less stable and controlled conditions arising from 
infection as compared to standard culturing procedures. To compute differential gene 
expression for M. bovis BCG and THP-1 cells, we took a conservative approach and assigned 
the same BCV to datasets EGB and THP as those obtained from IF1/2ER and IF1/2, 
respectively. Differential expression was then computed for each gene using a pairwise exact 
testing procedure. The algorithm of Benjamini and Hochberg was used to control false 
discovery rates [72]. Protein-coding genes and sRNA-coding genes with an FDR < 0.05 were 
assumed to be differentially expressed. 
For THP-1 cells, gene counts from dataset THP were compared to those of datasets IF1/2. 
Differential gene expression analysis was performed similar to M. bovis BCG. The low 
expression tags cutoff of 100 counts per million was normalized for the number of genes in 
the THP-1 genome. Afterwards, we used InnateDB and pathway enrichment analysis to 
identify induced host pathways [52]. 
Sequencing depth simulation 
Subsets of 50-bp sequencing reads, where both pairs aligned to the complete genome of M. 
bovis BCG, were taken randomly from dataset EGB and IF1ER. These subsets were of the 
same size (3.35 M) as the total number of sequencing reads from dataset IF2ER aligning to 
the M. bovis BCG genome in pairs (Figure 2A). From these two subsets, and from the paired-
end sequencing reads of IF2ER aligning to the M. bovis BCG genome, random sets of reads 
were chosen of different sizes. For each different size, five random sets were generated. 
Differential gene expression for M. bovis BCG was determined using the method described 
above (data analysis pipeline) for every set. The mean and standard deviation of the number 
of differentially expressed genes was calculated (Figure 2B). 
Compendium of expression data 
A compendium containing 565 two-color microarrays for M. tuberculosis (strain H37Rv) was 
obtained from literature [73] and most of these (454) captured the effect of 75 drugs targeting 
metabolic pathways [74,75] whereas 111 captured stress-induced dormancy in the wild-type 
and in DosR activation genes in KO mutants [76,77]. 
Quantitative real time PCR 
To verify the expression of several genes and small RNA's, their expression was determined 
using qRT-PCR. For 13 genes, we designed primers (Additional file 4) and quantified their 
relative expression to the reference gene: rpoB (BCG0716; Rv0667). This gene encodes the 
RNA polymerase β-subunit and is thought to be a housekeeping gene, which was used as 
such in previous qRT-PCR studies [78-80]. Fold changes in gene expression (Additional file 
5) were calculated using the ∆∆Ct, as described previously [81]. 
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Additional files provided with this submission:
Additional file 1. Comparison between non-enriched and enriched datasets. The normalized counts of each gene for both,
M. bovis BCG (A and B) and THP-1 cells (C and D), of the non-enriched datasets were plotted versus the enriched
datasets. The Pearson's correlation coefficients are denoted by an r in the lower right corner of each plot. The correlations
for M. bovis BCG genes between non-enriched and enriched datasets, are higher than those of the THP-1 genes (2124k)
http://www.biomedcentral.com/content/supplementary/s12864-014-1197-2-s1.pdf
Additional file 2. Differential expression of M. bovis BCG genes. Excel file with all expressed M. bovis BCG protein-
coding genes, M. bovis BCG small RNA genes, THP-1 genes, induced THP-1 pathways and repressed THP-1 pathways
(5669k)
http://www.biomedcentral.com/content/supplementary/s12864-014-1197-2-s2.xls
Additional file 3. Cholesterol degradation pathway. Genes in green are induced upon infection (FDR < 0.05), genes in
black show no differential expression. Dashed arrows represent multiple reactions. The degradation of the ring C and D side
chain is based on homologous genes from Rhodococcus equi. AD: 4-androstenedione, ADD: 1,4-androstenedione,
9OHADD: 9-hydroxy-1,4, androstene-3-17-dione, 3-HSA: 3-hydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione 3,4-
DHSA: 3,4-dihydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione 4,9 DSHA: 4,5-9,10-diseco-3-hydroxy-5,9,17-
trioxoandrosta-1(10),2-diene-4-oic acid, HDD: 2-hydroxy-hexa-2,4-dienoic acid, HIP: 9,17-dioxo-1,2,3,4,10,19-
hexanorandrostan-5-oic acid, 5OH-HIP: 5-hydroxy-methylhexahydro-1-indanone propionate. * In M. tuberculosis H37Rv,
cyp142 has the same function as cyp125. In M. bovis BCG, cyp142 contains a single nucleotide deletion resulting in a
premature stop codon and an inactive gene product. This gene (cyp142a) is two-fold induced upon infection (582k)
http://www.biomedcentral.com/content/supplementary/s12864-014-1197-2-s3.pdf
Additional file 4. Primers used for qPCR. Word document containing 14 primer pairs used for qPCR of selected M. bovis
BCG genes (100k)
http://www.biomedcentral.com/content/supplementary/s12864-014-1197-2-s4.docx
Additional file 5. Differential expression of selected M. bovis BCG genes using qPCR. Excel file with Ct numbers for a
variety of selected genes and sRNAs of M. bovis BCG. Fold changes in expression were calculated for these genes and
sRNAs (60k)
http://www.biomedcentral.com/content/supplementary/s12864-014-1197-2-s5.xlsx
Additional file 6. Central carbon metabolism. Genes in green are induced, and genes in red are repressed upon infection
(FDR < 0.05), genes in black show no differential expression. The genes in the methylcitrate cycle are induced upon
infection. *In M. tuberculosis H37Rv, icl2 is fragmented into aceAa and aceAb and non-functional (396k)
http://www.biomedcentral.com/content/supplementary/s12864-014-1197-2-s6.pdf
